Translational Neurodegeneration (Apr 2020)
Correction to: Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study
Abstract
An amendment to this paper has been published and can be accessed via the original article.